Dr.Reddy's Laboratories have announced the launch of Somazina, the innovator brand of Citicolin in India. Dr. Reddy's has partnered with Ferrer International S.A., Spain, the global innovator of Citicoline, to make Somazina available in India.
The drug is vital in the management of stroke and has been used for the treatment of post-stroke patients around the world.
How to Deal with a Stroke
Stroke is a brain attack, which occurs when the blood supply to the brain is interrupted. It affects all age groups; according to the WHO, 15 million people are affected by stroke annually.
Advertisement
Somazina is indicated to improve cognitive function in patients who have suffered from stroke or cerebral infarction, or who have undergone a brain surgery or have suffered from head injuries.
The brand, Citicoline is widely used as a neuro-protectant to help accelerate the recovery from stroke. It is used in both ischemic and haemorrhagic strokes, and provides a compelling option to physicians treating stroke patients.
![Stroke]( "Stroke")
Stroke can cause permanent disability and it is important to recognize its early warning signs to stop its progress. Early warning signs of stroke include sudden weakness of facial muscles.
"Citicoline is safe to use and may have a beneficial effect in stroke patients. Citicoline is the only drug, that in a number of different clinical stroke trials, has had some neuroprotective effect." shared Dr. Atul Prasad, Director & Sr. Consultant, BLK Super specialty hospital, Delhi.
Cerebral Stroke is the third leading cause of deaths in India, as per the Global Burden of Disease Study 2013. "Stroke is a major cause of disability and death in India. There is a pressing need for novel neuroprotective agents which can salvage brain tissue and optimize the functional outcome," said Subhash Kaul, renowned senior neurologist from NIMS, Hyderabad.
Source: Medindia
Stroke
Stroke can cause permanent disability and it is important to recognize its early warning signs to stop its progress. Early warning signs of stroke include sudden weakness of facial muscles.
Advertisement
"Citicoline is safe to use and may have a beneficial effect in stroke patients. Citicoline is the only drug, that in a number of different clinical stroke trials, has had some neuroprotective effect." shared Dr. Atul Prasad, Director & Sr. Consultant, BLK Super specialty hospital, Delhi.
Cerebral Stroke is the third leading cause of deaths in India, as per the Global Burden of Disease Study 2013. "Stroke is a major cause of disability and death in India. There is a pressing need for novel neuroprotective agents which can salvage brain tissue and optimize the functional outcome," said Subhash Kaul, renowned senior neurologist from NIMS, Hyderabad.
Source: Medindia
Stroke Survivors Need Emotional Support
About 152,000 individuals in England are affected by stroke annually. The repercussions of stroke include both physical disability and emotional stress.
Advertisement
 Apixaban : New Stroke Drug Available on NHSA new drug apixaben is now available that can treat stroke resulting from atrial fibrillation more effectively. | Advertisement
|
Advertisement
Latest Drug News
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.